A carregar...
Cutaneous Adverse Events in Newly Approved FDA Non-cancer Drugs: A Systematic Review
The prevalence of cutaneous adverse events attributable to newly approved anti-cancer drugs has been well reviewed in the dermatologic literature. In contrast, over 75% of US Food and Drug Administration approvals in the past 5 years have been for non-cancer drugs and indications. This represents mu...
Na minha lista:
| Publicado no: | Drugs R D |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7419407/ https://ncbi.nlm.nih.gov/pubmed/32557274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-020-00311-6 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|